Schwartz Investment Counsel Inc Abb Vie Inc. Transaction History

Schwartz Investment Counsel Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $37,310 - $42,792	-278 Reduced 13.09%	1,846 $248,000
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $170,960 - $230,815	2,124 New	2,124 $228,000
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $191,063 - $224,245	-2,224 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $163,174 - $218,352	2,224 New	2,224 $218,000
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $154,800 - $234,696	-2,400 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $173,112 - $216,600	2,400 New	2,400 $212,000
Q1 2019 May 02, 2019	SELL	$77.14 - $90.79 $185,136 - $217,896	-2,400 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$69.85 - $89.22 $167,640 - $214,128	2,400	2,400 $213,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Schwartz Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Schwartz Investment Counsel Inc with notifications on news.